Cancer Genetics was founded in 1999 and is headquartered in Rutherford, US

President & CEO

Cancer Genetics has offices in Rutherford, Morrisville, Los Angeles, Shanghai and in 1 other location

Rutherford, US (HQ)

Complex 201 Route 17 North

Shanghai, CN

Zhong Guo Yi Dong （ Cai Lun Lu ）

Los Angeles, US

Health Research Association 1640 Marengo St

Morrisville, US

133 Southcenter Ct

Cancer Genetics's revenue was reported to be $7 m in Q1, 2017

USD

## Revenue (Q1, 2017) | 7 m |

## Gross profit (Q1, 2017) | 2.8 m |

## Gross profit margin (Q1, 2017), % | 40% |

## EBIT (Q1, 2017) | (2.8 m) |

## Market capitalization (21-Jul-2017) | 72.8 m |

## Cash (31-Mar-2017) | 9.7 m |

Cancer Genetics's current market capitalization is $72.8 m.

USD | FY, 2013^{} | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} |
---|---|---|---|---|

## Revenue | 6.6 m | 10.2 m | 18 m | 27 m |

## Revenue growth, % | 54% | 77% | 50% | |

## Cost of goods sold | 4.9 m | 8.5 m | 14.1 m | 17.1 m |

## Gross profit | 1.7 m | 1.7 m | 3.9 m | 9.9 m |

## Gross profit Margin, % | 25% | 17% | 22% | 37% |

## Sales and marketing expense | 4.7 m | |||

## R&D expense | 6 m | |||

## General and administrative expense | 16 m | |||

## Operating expense total | 10.1 m | 21 m | 25.3 m | 26.7 m |

## EBIT | (8.4 m) | (18.3 m) | (20.7 m) | (16.7 m) |

## EBIT margin, % | (128%) | (179%) | (115%) | (62%) |

## Interest expense | (2.4 m) | (472.8 k) | (344 k) | (454 k) |

## Interest income | 29.7 k | 73.8 k | 49 k | 23 k |

## Pre tax profit | (13 m) | (19 m) | (21.4 m) | (15.8 m) |

## Income tax expense | (663.9 k) | (2.4 m) | ||

## Net Income | (12.4 m) | (16.6 m) | (20.2 m) | (15.8 m) |

USD | Q2, 2014^{} | Q3, 2014^{} | Q1, 2015^{} | Q2, 2015^{} | Q3, 2015^{} | Q1, 2016^{} | Q2, 2016^{} | Q3, 2016^{} | Q1, 2017^{} |
---|---|---|---|---|---|---|---|---|---|

## Revenue | 1.5 m | 3.2 m | 4.4 m | 4.2 m | 4 m | 6.1 m | 7 m | 6.8 b | 7 m |

## Cost of goods sold | 1.5 m | 2.6 m | 3.1 m | 3.1 m | 3.1 m | 4.1 m | 4.3 m | 4.4 b | 4.2 m |

## Gross profit | 8.6 k | 656.1 k | 1.2 m | 1.1 m | 897.1 k | 2 m | 2.7 m | 2.3 b | 2.8 m |

## Gross profit Margin, % | 1% | 20% | 28% | 26% | 22% | 32% | 39% | 34% | 40% |

## Sales and marketing expense | 918.5 k | 1.1 m | 1.1 m | 1.2 m | 1.2 m | 1.3 m | 1.4 m | 1.1 b | 971 k |

## R&D expense | 1.1 m | 1.4 m | 1.3 m | 1.3 m | 1.8 m | 1.5 m | 1.7 m | 1.6 b | 1.1 m |

## General and administrative expense | 2.4 m | 3.1 m | 3 m | 3.1 m | 3.5 m | 4.3 m | 3.7 m | 3.7 b | 3.5 m |

## Operating expense total | 4.4 m | 5.6 m | 5.4 m | 5.5 m | 6.5 m | 7.1 m | 6.7 m | 6.3 b | 5.6 m |

## EBIT | (4.4 m) | (4.9 m) | (4.2 m) | (4.4 m) | (5.6 m) | (5.2 m) | (4 m) | (4 b) | (2.8 m) |

## EBIT margin, % | (292%) | (152%) | (95%) | (105%) | (141%) | (85%) | (57%) | (60%) | (40%) |

## Interest expense | (30.7 k) | (36.2 k) | (34 k) | (81.6 k) | (111.6 k) | (126 k) | (107 k) | (111 m) | (194 k) |

## Interest income | 16.2 k | 18.8 k | 12.6 k | 12.8 k | 4.9 k | 4 k | 13 k | 4 m | 17 k |

## Pre tax profit | (4.2 m) | (4.8 m) | (4.3 m) | (5 m) | (5.2 m) | (10.6 m) | |||

## Net Income | (6.7 m) |

USD | FY, 2013^{} | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} |
---|---|---|---|---|

## Cash | 49.5 m | 25.6 m | 19.5 m | 9.5 m |

## Current Assets | 51.9 m | 31.8 m | 28.2 m | 23.4 m |

## PP&E | 1.3 m | 4.4 m | 6.1 m | 4.7 m |

## Goodwill | 3 m | 12 m | 12 m | |

## Total Assets | 55.2 m | 47.1 m | 48.9 m | 42.4 m |

## Accounts Payable | 2.3 m | 3.8 m | 7.6 m | 8.1 m |

## Current Liabilities | 8.6 m | 4.4 m | 9.9 m | 11 m |

## Total Liabilities | 16.8 m | |||

## Additional Paid-in Capital | 106.8 m | 112.5 m | 131.2 m | 139.6 m |

## Retained Earnings | (61.3 m) | (98.2 m) | (114 m) | |

## Total Equity | 45.5 m | 33 m | 25.6 m | |

## Financial Leverage | 1.2 x | 1.5 x | 1.7 x |

USD | Q2, 2015^{} | Q3, 2015^{} | Q1, 2016^{} | Q2, 2016^{} | Q3, 2016^{} | Q1, 2017^{} |
---|---|---|---|---|---|---|

## Cash | 23.7 m | 19.9 m | 13.3 m | 10.6 m | 10.7 m | 9.7 m |

## Current Assets | 31.1 m | 3.8 m | 23.5 m | 24.5 m | 26.6 m | 24.4 m |

## PP&E | 3.9 m | 5.9 m | 5.4 m | 4.9 m | 4.8 m | |

## Goodwill | 3.2 m | 3.2 m | 12 m | 12 m | 12 m | 12 m |

## Total Assets | 39.8 m | 36 m | 44 m | 44.2 m | 45.8 m | 43.4 m |

## Accounts Payable | 4.1 m | 4.4 m | 7.8 m | 7.6 m | 8.3 m | 8.1 m |

## Current Liabilities | 4.8 m | 6.5 m | 10.3 m | 10.1 m | 10.6 m | 8.8 m |

## Additional Paid-in Capital | 114 m | 114.8 m | 131.7 m | 136.6 m | 139 m | 144.5 m |

## Total Equity | 26.8 m | 22.3 m | 28.3 m | 29.2 m | 27.8 m | 20.9 m |

## Financial Leverage | 1.5 x | 1.6 x | 1.6 x | 1.5 x | 1.6 x | 2.1 x |

USD | FY, 2013^{} | FY, 2014^{} | FY, 2015^{} | FY, 2016^{} |
---|---|---|---|---|

## Net Income | (12.4 m) | (16.6 m) | (20.2 m) | (15.8 m) |

## Depreciation and Amortization | 311.2 k | 810.2 k | 1.5 m | 2 m |

## Accounts Receivable | (716.5 k) | (1.7 m) | (1.7 m) | (5.9 m) |

## Cash From Operating Activities | 48.6 m | (23.9 m) | (6.1 m) | |

## Purchases of PP&E | (257.3 k) | (1.4 m) | (1 m) | (490 k) |

## Cash From Investing Activities | (1.4 m) | (11.4 m) | (2.6 m) | (609 k) |

## Short-term Borrowings | (3.6 m) | (408.4 k) | (1.3 m) | |

## Cash From Financing Activities | 58.1 m | 10.1 m | 8.5 m | |

## Interest Paid | 608.1 k | 128.4 k | 240 k | 333 k |

USD | Q2, 2014^{} | Q3, 2014^{} | Q1, 2015^{} | Q2, 2015^{} | Q3, 2015^{} | Q1, 2016^{} | Q2, 2016^{} | Q3, 2016^{} | Q1, 2017^{} |
---|---|---|---|---|---|---|---|---|---|

## Net Income | (6.7 m) | ||||||||

## Depreciation and Amortization | 214.5 k | 487.7 k | 347.7 k | 679.6 k | 971.2 k | 518 k | 1 m | 1.5 m | 534 k |

## Accounts Receivable | (489.2 k) | (521.4 k) | (17.2 k) | (909.9 k) | (349.4 k) | (1.8 m) | (5.3 m) | (7.1 m) | (901 k) |

## Purchases of PP&E | (385.2 k) | (944.4 k) | (83.1 k) | (257.5 k) | (439.7 k) | (319 k) | (319 k) | (345 k) | (178 k) |

## Cash From Investing Activities | (6.4 m) | (10.9 m) | (123.2 k) | 5.7 m | 4.6 m | (358 k) | (405 k) | (472 k) | (209 k) |

## Short-term Borrowings | (22.3 k) | (127.5 k) | |||||||

## Cash From Financing Activities | 218.9 k | 108 k | (124.9 k) | (257.3 k) | 4.1 m | 9 m | 2.8 m | ||

## Interest Paid | 61.4 k | 92.7 k | 33.9 k | 72.3 k | 157.6 k | 97 k | 202 k | 250 k | 269 k |

USD | Y, 2017 |
---|---|

## Revenue/Employee | 38.2 k |

## Financial Leverage | 2.1 x |